| Authors: |
Bataller A; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chien KS; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sasaki K; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Montalban-Bravo G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kanagal-Shamanna R; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Urrutia S; Department of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Almanza-Huante E; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gener-Ricos G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour E; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia T; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borthakur G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: ggarciam@mdanderson.org. |
